騰訊(00700.HK)成立地圖產品部及數字孿生產品部
內媒報道,騰訊(00700.HK)內部公布調整騰訊雲與智慧產業事業群(CSIG)組織架構和部分管理幹部,並宣布將成立地圖產品部及數字孿生產品部,同時撤銷智慧空間產品部及交通平台產品部。
新成立的地圖產品部預期主要負責騰訊地圖和出行等面向C端用戶的業務;數字孿生產品部主要負責搭建面向B端的生產空間、道路、園區和建築等領域的數字孿生底座和應用產品。
今次撤銷的智慧空間產品部與交通平台產品部,相關團隊將調至數字孿生產品部。而地圖產品部負責人由張治東負責,其不再擔任地圖平台部總經理;數字孿生產品部總經理為萬超,兩人均向騰訊公司副總裁鍾翔平匯報。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.